Halozyme Therapeutics Inc (HALO)

19.07 -0.59  -3.03% NASDAQ Jan 24, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/21/2020 16:30 EST Misc Halozyme Therapeutics Inc Fourth Quarter Earnings Conference Call in 2019
02/21/2020 Earnings Halozyme Therapeutics Inc Fourth Quarter Earnings in 2019 Release
11/12/2019 16:30 EST Misc Halozyme Therapeutics Inc Third Quarter Earnings Conference Call for 2019
11/12/2019 Earnings Halozyme Therapeutics Inc Third Quarter Earnings for 2019 Release
08/06/2019 16:30 EDT Misc Halozyme Therapeutics Inc Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings Halozyme Therapeutics Inc Second Quarter Earnings in 2019 Release
05/07/2019 16:30 EDT Misc Halozyme Therapeutics Inc First Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Halozyme Therapeutics Inc First Quarter Earnings in 2019 Release
05/02/2019 Misc Halozyme Therapeutics Inc Annual General Meeting in 2018
02/21/2019 16:30 EST Misc Halozyme Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.halozyme.com
  • Investor Relations URL: http://www.halozyme.com/investors/default.aspx
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 21, 2020
  • Last Earnings Release: Nov. 12, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Top Fund Holders

Symbol Name Weighting
EAFRX First Eagle Fund of America R4 2.45%
BBP Virtus LifeSci Biotech Products ETF 2.35%
ARTSX Artisan Small Cap Investor 1.78%
HRSOX Harbor Small Cap Growth Opps Admin 1.29%
VASMX VALIC Company II Small Cap Growth 1.22%
JGLYX JPMorgan Small Cap Growth R4 1.22%
FVUSA04AWV JNL/Invesco Small Cap Growth I 1.04%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.